Yahoo Finance • 2 months ago
Investing.com -- Here are some of the biggest stock movers ahead of the opening bell: Daqo New Energy (NYSE:DQ) shares were down around 7% after the polysilicon maker reported a loss in its second quarter, compared to prior year's profit,... Full story
Yahoo Finance • 3 months ago
Cathie Wood is struggling to get the balance right in her growth stock portfolios. The Ark Invest co-founder, CEO, and chief investment officer is losing to the market for the third time in the last four years. She's trying not to keep it... Full story
Yahoo Finance • 6 months ago
Key Insights Guardant Health's estimated fair value is US$39.63 based on 2 Stage Free Cash Flow to Equity Current share price of US$22.37 suggests Guardant Health is potentially 44% undervalued The US$38.94 analyst price target for GH is... Full story
Yahoo Finance • 9 months ago
In the last year, multiple insiders have substantially increased their holdings of Guardant Health, Inc. (NASDAQ:GH) stock, indicating that insiders' optimism about the company's prospects has increased. While we would never suggest that... Full story
Yahoo Finance • 10 months ago
Cathie Wood crushed it in 2023. Her flagship Ark Innovation ETF(NYSEMKT: ARKK) soared nearly 67%. The Ark Next Generation Internet ETF(NYSEMKT: ARKW) performed even better with an impressive 97% gain. If analysts are right, Wood could hav... Full story
Yahoo Finance • 11 months ago
PALO ALTO, Calif., December 21, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with Baillie Gifford on behalf of a... Full story
Yahoo Finance • 12 months ago
PALO ALTO, Calif., November 15, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it intends to appeal yesterday’s verdict in the U.S. District Court for the District of Delawa... Full story
Yahoo Finance • last year
PALO ALTO, Calif., November 03, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences: Jefferies 14th Annual Glo... Full story
Yahoo Finance • last year
In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongo... Full story
Yahoo Finance • last year
Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Guardant Health Inc (NASDAQ:GH). The stock, which is currently priced at 31.26, recorded a loss... Full story
Yahoo Finance • last year
First blood-only liquid biopsy test for minimal residual disease now covered for patients with stage II or III colorectal cancer Test used after surgery or curative treatment to inform physician decisions about adjuvant therapy and to moni... Full story
Yahoo Finance • last year
Reimbursement supports expanded access to blood-based comprehensive genomic profiling with Guardant360 CDx for patients with advanced solid tumor cancers and their care teams across Japan PALO ALTO, Calif., July 05, 2023--(BUSINESS WIRE)-... Full story
Yahoo Finance • 2 years ago
In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US hav... Full story
Yahoo Finance • 2 years ago
The data from the pivotal ECLIPSE Study accepted as a late-breaking abstract highlights the performance of the Shield™ blood test in detecting colorectal cancer in asymptomatic patients PALO ALTO, Calif., April 21, 2023--(BUSINESS WIRE)--... Full story
Yahoo Finance • 2 years ago
After January’s stock rally, the story in the markets for the past two months has been volatility. Stocks were on a seesaw even before the recent SVB crash, and the banking woes of the last two weeks have simply exacerbated the up and down... Full story
Yahoo Finance • 2 years ago
Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic development Phase 3 study is supported by previously presented ELAINE-1 and ELAINE-2 Phase 2 study resultsSermonix antici... Full story
Yahoo Finance • 2 years ago
The move comes about a month after the company's stock dropped by about 30% when it reported trial results of a test for colorectal cancer that disappointed some of its investors. Continue reading... Full story
Yahoo Finance • 2 years ago
Stock futures pointed to a weak start for Wall Street on Friday after stocks sank during the previous session on fears of rising interest rates and worries over a possible U.S. recession. Adobe (ticker: ADBE) rose rose 4.2% in premarket tr... Full story
Yahoo Finance • 2 years ago
Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and s... Full story
Yahoo Finance • 2 years ago
Blood test provides simple way to test patients comprehensively for tumor alterations that drive selection of targeted therapies, now including ENHERTU PALO ALTO, Calif., August 12, 2022--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH... Full story